According to media outlet SBS, Georgia has become the first state to allow the sale of medical marijuana in regular pharmacies. The Georgia Pharmacy Board began accepting applications for the sale of medical marijuana earlier this month.
As of now, over 120 out of more than 400 privately-owned pharmacies in Georgia have expressed their willingness to sell the medical cannabis oil from "Botanical Science" company. These pharmacies are expected to start selling medical cannabis shortly after the completion of a state government field inspection.
Although 38 states in the United States have legalized the use of medical marijuana, its purchase is currently limited to specialized marijuana dispensaries with government permits. If regular pharmacies were allowed to sell medical marijuana oil, the purchasing process for patients with prescriptions would become more convenient.
In 2019, the state of Georgia approved applications for the purchase of medical marijuana for patients suffering from epilepsy, late-stage cancer, and Parkinson's disease. Governor Brian Kemp of Georgia recently approved regulations for the sale of medical marijuana proposed by the Board of Pharmacy.
With a doctor's prescription and a registration certificate issued by the state government, patients and caregivers only need to present their identification cards to legally purchase medical cannabis oil under the guidance of a pharmacist.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
